nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—Danazol—Hydrocortisone—psoriasis	0.149	0.159	CrCrCtD
Trilostane—Danazol—Prednisone—psoriasis	0.128	0.137	CrCrCtD
Trilostane—Progesterone—Hydrocortisone—psoriasis	0.109	0.116	CrCrCtD
Trilostane—Methyltestosterone—Hydrocortisone—psoriasis	0.106	0.113	CrCrCtD
Trilostane—Testosterone—Hydrocortisone—psoriasis	0.0947	0.101	CrCrCtD
Trilostane—Progesterone—Prednisolone—psoriasis	0.0917	0.0976	CrCrCtD
Trilostane—Methyltestosterone—Prednisone—psoriasis	0.0916	0.0975	CrCrCtD
Trilostane—Methyltestosterone—Prednisolone—psoriasis	0.0894	0.0951	CrCrCtD
Trilostane—Testosterone—Prednisolone—psoriasis	0.0796	0.0847	CrCrCtD
Trilostane—HSD3B1—Corticotropin-releasing hormone—IVL—psoriasis	0.00776	0.129	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—IVL—psoriasis	0.00588	0.098	CbGpPWpGaD
Trilostane—ESR2—Ovarian Infertility Genes—VDR—psoriasis	0.00154	0.0256	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL23A—psoriasis	0.00145	0.0242	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.00143	0.0239	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptors—VDR—psoriasis	0.00134	0.0223	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.00109	0.0181	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—VDR—psoriasis	0.00106	0.0177	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—TGFA—psoriasis	0.00105	0.0174	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.00102	0.017	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptors—PPARG—psoriasis	0.000935	0.0156	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000915	0.0153	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000853	0.0142	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NDUFA5—psoriasis	0.000804	0.0134	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000802	0.0134	CbGpPWpGaD
Trilostane—ESR1—Estrogen Receptor Pathway—JUN—psoriasis	0.000788	0.0131	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.000784	0.0131	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—CXCL8—psoriasis	0.000775	0.0129	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.00075	0.0125	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000739	0.0123	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000727	0.0121	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000694	0.0116	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP2S1—psoriasis	0.000684	0.0114	CbGpPWpGaD
Trilostane—ESR1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000682	0.0114	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—VDR—psoriasis	0.000676	0.0113	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL13—psoriasis	0.000674	0.0112	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—REL—psoriasis	0.000667	0.0111	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NDUFA5—psoriasis	0.000609	0.0102	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000583	0.00971	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000568	0.00947	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.000538	0.00898	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000534	0.00891	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP2S1—psoriasis	0.000518	0.00864	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—JUN—psoriasis	0.0005	0.00833	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	0.000481	0.00801	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—PPARG—psoriasis	0.000471	0.00786	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—TARS—psoriasis	0.000469	0.00782	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	0.000437	0.00728	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL10—psoriasis	0.000421	0.00702	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000405	0.00674	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL10—psoriasis	0.000403	0.00672	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.000395	0.00659	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL4—psoriasis	0.000392	0.00654	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000372	0.00621	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	0.000369	0.00615	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	0.000359	0.00598	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000358	0.00597	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	0.000357	0.00595	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	0.000356	0.00593	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	0.000355	0.00591	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CARM1—psoriasis	0.000334	0.00557	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000327	0.00545	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—LEP—psoriasis	0.000314	0.00524	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000312	0.0052	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—CARM1—psoriasis	0.000306	0.00511	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—JUN—psoriasis	0.000297	0.00496	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000276	0.0046	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000275	0.00458	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	0.000272	0.00453	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000272	0.00453	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CARM1—psoriasis	0.000253	0.00422	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	0.000253	0.00422	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000251	0.00418	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—IFNG—psoriasis	0.000243	0.00405	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IFNG—psoriasis	0.000237	0.00395	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000237	0.00394	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—TARS—psoriasis	0.000236	0.00394	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	0.000236	0.00393	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—JUN—psoriasis	0.000235	0.00392	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.00023	0.00384	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	0.000221	0.00368	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	0.00022	0.00367	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000215	0.00358	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—JUN—psoriasis	0.000214	0.00357	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—JUN—psoriasis	0.00021	0.0035	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000206	0.00344	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CAT—psoriasis	0.000205	0.00342	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—JUN—psoriasis	0.000205	0.00342	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—NFKB1—psoriasis	0.000202	0.00337	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—TP53—psoriasis	0.0002	0.00333	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000187	0.00312	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—NFKB1—psoriasis	0.000187	0.00311	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—VDR—psoriasis	0.000183	0.00305	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	0.000182	0.00304	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000182	0.00304	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000175	0.00292	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—STAT3—psoriasis	0.000168	0.0028	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000165	0.00275	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TNF—psoriasis	0.00016	0.00267	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOE—psoriasis	0.00016	0.00266	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000159	0.00265	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CAT—psoriasis	0.000156	0.00259	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—CARM1—psoriasis	0.000155	0.00258	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—CARM1—psoriasis	0.000148	0.00246	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL6—psoriasis	0.000142	0.00237	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARG—psoriasis	0.000139	0.00232	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000139	0.00231	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	0.000136	0.00227	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—TYK2—psoriasis	0.000136	0.00227	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TP53—psoriasis	0.000135	0.00226	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL6—psoriasis	0.000129	0.00216	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARG—psoriasis	0.000128	0.00213	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL6—psoriasis	0.000124	0.00207	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOE—psoriasis	0.000121	0.00202	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.00012	0.002	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	0.000111	0.00185	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HCAR2—psoriasis	0.00011	0.00183	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	0.000107	0.00178	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARG—psoriasis	0.000105	0.00176	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	9.68e-05	0.00161	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TAGAP—psoriasis	9.5e-05	0.00158	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—VDR—psoriasis	9.23e-05	0.00154	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	9.19e-05	0.00153	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	8.84e-05	0.00147	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—VDR—psoriasis	8.81e-05	0.00147	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	8.02e-05	0.00134	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—CARM1—psoriasis	7.44e-05	0.00124	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	7.32e-05	0.00122	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.88e-05	0.00115	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6—psoriasis	6.66e-05	0.00111	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARG—psoriasis	6.43e-05	0.00107	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARG—psoriasis	6.14e-05	0.00102	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.06e-05	0.00101	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL20—psoriasis	5.69e-05	0.000948	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—VDR—psoriasis	4.44e-05	0.000741	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SOCS1—psoriasis	3.13e-05	0.000522	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARG—psoriasis	3.1e-05	0.000516	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LEP—psoriasis	2.31e-05	0.000385	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOE—psoriasis	2.31e-05	0.000385	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NFKBIA—psoriasis	2.15e-05	0.000359	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TYK2—psoriasis	1.76e-05	0.000294	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL8—psoriasis	1.54e-05	0.000256	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—JUN—psoriasis	1.43e-05	0.000238	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NFKB1—psoriasis	1.37e-05	0.000229	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VEGFA—psoriasis	1.25e-05	0.000208	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—STAT3—psoriasis	1.24e-05	0.000206	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TP53—psoriasis	9.43e-06	0.000157	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6—psoriasis	8.63e-06	0.000144	CbGpPWpGaD
